Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality
Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality
About this item
Full title
Author / Creator
Publisher
England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
The paradigm of bronchiectasis is shifting away from its exclusive characterization as a neutrophilic condition. Patients with bronchiectasis and high eosinophil levels have been found to have a specific phenotype, but the clinical effect of eosinopenia remains unclear.
A retrospective, single-center, observational study was conducted at a terti...
Alternative Titles
Full title
Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11700409
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11700409
Other Identifiers
ISSN
1479-9731,1479-9723
E-ISSN
1479-9731
DOI
10.1177/14799731241296847
